Goldvaser, H., Korzets, Y., Shepshelovich, D., Yerushalmi, R., Sarfaty, M., Ribnikar, D., . . . Amir, E. (2019). Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis. JNCI Cancer Spectr.
Chicago Style aipamenaGoldvaser, Hadar, Yasmin Korzets, Daniel Shepshelovich, Rinat Yerushalmi, Michal Sarfaty, Domen Ribnikar, Paaladinesh Thavendiranathan, and Eitan Amir. "Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis." JNCI Cancer Spectr 2019.
MLA aipamenaGoldvaser, Hadar, et al. "Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis." JNCI Cancer Spectr 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.